In the context of AML, the interaction between AF9 and MLL proteins is crucial for the regulation of gene expression, specifically facilitating the binding of the MLL enzyme complex to gene promoters in an active transcriptional state [70]. The gene discussed is MLLT3; the disease is acute myeloid leukemia.